Samsung Biologics Epix Quarterly Performance Trends /Photo=Lee Ji-hye Samsung Biologics Epix is leaping forward as a ...
Ariel Investments, an investment management company, released its “Ariel Appreciation Fund” Q3 2026 investor letter. A copy of the letter can be downloaded here. Copy main article 1st para. The Fund ...
ICSE, ISC date sheet 2027 is expected to be out soon. Check the expected CISCE Class 10, 12 timetable release, previous years ...
Amazon S3 on MSN
Arthritis drug class may aid virus spread in lab cells
A class of drugs prescribed for rheumatoid arthritis may help viruses spread in lab cells, according to a Norwegian ...
Busan will host the 2026 Bio-Health Forum on the 28th, proposing a medical AI and data council linking hospitals, companies and the city.
Latus Bio, Inc. (Latus), a biotechnology company engineering gene therapies at scale, today announced the publication of a ...
Is BIO a good stock to buy? We came across a bullish thesis on Bio-Rad Laboratories, Inc. on One Idea Per Day’s Substack by ...
Entera Bio Ltd. announced the appointment of clinical leader Juan Camilo Arjona Ferreira, M.D., as a Class II director of the Company, effective December 1, 2026. Dr. Arjona Ferreira will serve as a ...
The objective of the Fund is to achieve capital appreciation by investing primarily in U.S. equities. The Fund invests at least 80% of its net assets in equity securities of small U.S. companies. The ...
Financial News] ABL Bio Inc. is releasing clinical data on two bispecific immuno-oncology drug candidates and accelerating ...
Single administration of SERP-01 was associated with increases in total serum AAT above the protective threshold with durable correction out to ...
The phase III Krascendo 1 results demonstrate the potential for divarasib to become a new standard of care for people with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results